CA1143731A - Antiallergic and antiulcer 1-oxo-1h-tetrazolo¬3,2- a| pyrimidine-2-carboxylate therefor - Google Patents

Antiallergic and antiulcer 1-oxo-1h-tetrazolo¬3,2- a| pyrimidine-2-carboxylate therefor

Info

Publication number
CA1143731A
CA1143731A CA000365258A CA365258A CA1143731A CA 1143731 A CA1143731 A CA 1143731A CA 000365258 A CA000365258 A CA 000365258A CA 365258 A CA365258 A CA 365258A CA 1143731 A CA1143731 A CA 1143731A
Authority
CA
Canada
Prior art keywords
oxo
pyrimidine
compound
formula
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000365258A
Other languages
English (en)
French (fr)
Inventor
Saul B. Kadin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of CA1143731A publication Critical patent/CA1143731A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
CA000365258A 1979-11-23 1980-11-21 Antiallergic and antiulcer 1-oxo-1h-tetrazolo¬3,2- a| pyrimidine-2-carboxylate therefor Expired CA1143731A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23
US96,631 1979-11-23

Publications (1)

Publication Number Publication Date
CA1143731A true CA1143731A (en) 1983-03-29

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000365258A Expired CA1143731A (en) 1979-11-23 1980-11-21 Antiallergic and antiulcer 1-oxo-1h-tetrazolo¬3,2- a| pyrimidine-2-carboxylate therefor

Country Status (35)

Country Link
JP (1) JPS5687586A (es)
KR (1) KR830004322A (es)
AR (2) AR228859A1 (es)
AT (1) AT380883B (es)
AU (1) AU520995B2 (es)
BE (1) BE886319A (es)
CA (1) CA1143731A (es)
CH (1) CH649299A5 (es)
CS (1) CS241476B2 (es)
DD (1) DD154608A5 (es)
DE (2) DE3050491C2 (es)
DK (1) DK151811C (es)
EG (1) EG14929A (es)
ES (1) ES8203363A1 (es)
FI (1) FI67706C (es)
FR (1) FR2470132A1 (es)
GB (1) GB2063862B (es)
GR (1) GR72132B (es)
GT (1) GT198066458A (es)
HU (1) HU179091B (es)
IE (1) IE50404B1 (es)
IL (1) IL61535A (es)
IN (1) IN154926B (es)
IT (1) IT1209373B (es)
LU (1) LU82950A1 (es)
NL (1) NL182565C (es)
NO (1) NO803521L (es)
NZ (1) NZ195596A (es)
PH (1) PH16666A (es)
PL (1) PL132354B1 (es)
PT (1) PT72090B (es)
SE (1) SE448732B (es)
SU (1) SU1042620A3 (es)
YU (1) YU41953B (es)
ZA (1) ZA807293B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
ES2087072T3 (es) * 1988-03-28 1996-07-16 Janssen Pharmaceutica Nv Agentes para conservar o restablecer la salud de la piel.
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
JPS5687586A (en) 1981-07-16
FR2470132A1 (fr) 1981-05-29
GB2063862B (en) 1983-06-22
DE3043979A1 (de) 1981-09-03
PL228008A1 (es) 1981-12-11
HU179091B (en) 1982-08-28
NL182565C (nl) 1988-04-05
SE448732B (sv) 1987-03-16
DK151811B (da) 1988-01-04
NL8006362A (nl) 1981-06-16
AR228859A1 (es) 1983-04-29
ATA570780A (de) 1985-12-15
CH649299A5 (fr) 1985-05-15
ES497066A0 (es) 1982-04-01
CS782080A2 (en) 1985-06-13
YU295080A (en) 1983-06-30
IL61535A0 (en) 1980-12-31
FI803628L (fi) 1981-05-24
SE8008189L (sv) 1981-05-24
FI67706B (fi) 1985-01-31
FR2470132B1 (es) 1983-07-29
GB2063862A (en) 1981-06-10
AR231296A1 (es) 1984-10-31
BE886319A (fr) 1981-05-25
NO803521L (no) 1981-05-25
PT72090A (en) 1980-12-01
DD154608A5 (de) 1982-04-07
GT198066458A (es) 1982-05-15
PL132354B1 (en) 1985-02-28
JPS617432B2 (es) 1986-03-06
IL61535A (en) 1984-06-29
EG14929A (en) 1989-01-30
NL182565B (nl) 1987-11-02
IN154926B (es) 1984-12-22
DK151811C (da) 1988-06-06
AT380883B (de) 1986-07-25
CS241476B2 (en) 1986-03-13
PT72090B (en) 1981-09-29
SU1042620A3 (ru) 1983-09-15
KR830004322A (ko) 1983-07-09
IE802418L (en) 1981-05-23
DK413180A (da) 1981-05-24
DE3043979C2 (de) 1986-08-21
FI67706C (fi) 1985-05-10
ES8203363A1 (es) 1982-04-01
IT1209373B (it) 1989-07-16
GR72132B (es) 1983-09-19
IT8026176A0 (it) 1980-11-21
DE3050491C2 (de) 1985-10-10
NZ195596A (en) 1984-05-31
AU520995B2 (en) 1982-03-11
IE50404B1 (en) 1986-04-16
PH16666A (en) 1983-12-13
LU82950A1 (fr) 1981-06-04
AU6459580A (en) 1981-05-28
ZA807293B (en) 1981-12-30
YU41953B (en) 1988-02-29

Similar Documents

Publication Publication Date Title
CA1109870A (en) Azolopyrimidinones
US4041163A (en) N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
IE45744B1 (en) Anti-allergenic 5-alkoxyimidazo (1,2-a)-quinoline-2-carboxylic acids and derivatives thereof
JPH09301958A (ja) 新規ピリミジン化合物及び抗ロタウイルス剤
CA1143731A (en) Antiallergic and antiulcer 1-oxo-1h-tetrazolo¬3,2- a| pyrimidine-2-carboxylate therefor
US4734413A (en) Substituted 1,2,4-triazolo[1,5-A]triazines as bronchodilators
US4423048A (en) Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US4535081A (en) Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US3468888A (en) 2-substituted pyrimido(1,2-a) benzimidazoles
US4414388A (en) 1-Oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides
FI83650B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.
US4705787A (en) Quinazolinone derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
CA1088064A (en) 2,5-dihydro-1,2-thiazino[5,6-b]indol-3- carboxamides-1,1-dioxides, processes for their preparation and their pharmaceutical compositions
KR920000271B1 (ko) 1,2,4-트리아조로[1,5-c] 피리미딘 및 이의 제조방법
CA1060441A (en) Anti-allergic n-(5-tetrazolyl)-1-oxo-1h-6-alkox-ypyrimido (1,2-a)-quinoline-2-carboxamides and intermediates therefor
JPH01319487A (ja) イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
US4269774A (en) Thiazolo[5,4-d][2]benzazepines
US4254121A (en) 3-Oxo-5H-pyrimido[2,1-c][1,4 ]benzoxazines
FI71158C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-xo-1h-tiazolo/3,2-a/pyrimidin-2-karboxylsyror
US4491587A (en) Tetrazole derivatives
JPH08134044A (ja) 新規ピリミジン化合物、中間体及びそれらの製造法
US4761474A (en) 3-(1H-tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones
US4692444A (en) 1,4-Dihydro[1]benzothiopyrano[4,3-c]pyrazole derivatives, compositions containing them, and pharmacological methods of using them
US4336388A (en) Thiazolyl benzophenone compounds
JPS61134389A (ja) トリアジノン誘導体および抗潰瘍剤

Legal Events

Date Code Title Description
MKEX Expiry